1. Tavassoli FA. Pathology of the Breast. 2nd ed. New York: McGraw-Hill;1999. p. 333–339.
2. Abdul Rashid S, Rahmat K, Jayaprasagam K, Alli K, Moosa F. Medullary carcinoma of the breast: role of contrast-enhanced MRI in the diagnosis of multiple breast lesions. Biomed Imaging Interv J. 2009; 5:e27.
Article
3. Li CI. Risk of mortality by histologic type of breast cancer in the United States. Horm Cancer. 2010; 1:156–165.
Article
4. Weigelt B, Horlings HM, Kreike B, Hayes MM, Hauptmann M, Wessels LF, et al. Refinement of breast cancer classification by molecular characterization of histological special types. J Pathol. 2008; 216:141–150.
Article
5. Moore OS Jr, Foote FW Jr. The relatively favorable prognosis of medullary carcinoma of the breast. Cancer. 1949; 2:635–642.
Article
6. Cotran RS, Kumar V, Collins T, Robbins SL. Robbins Pathologic Basis of Disease. 6th ed. Philadelphia: Saunders;1999. p. 1111.
7. Ridolfi RL, Rosen PP, Port A, Kinne D, Miké V. Medullary carcinoma of the breast: a clinicopathologic study with 10 year follow-up. Cancer. 1977; 40:1365–1385.
Article
8. Foschini MP, Eusebi V. Rare (new) entities of the breast and medullary carcinoma. Pathology. 2009; 41:48–56.
Article
9. Li CI, Uribe DJ, Daling JR. Clinical characteristics of different histologic types of breast cancer. Br J Cancer. 2005; 93:1046–1052.
Article
10. Vu-Nishino H, Tavassoli FA, Ahrens WA, Haffty BG. Clinicopathologic features and long-term outcome of patients with medullary breast carcinoma managed with breast-conserving therapy (BCT). Int J Radiat Oncol Biol Phys. 2005; 62:1040–1047.
Article
11. Vo T, Xing Y, Meric-Bernstam F, Mirza N, Vlastos G, Symmans WF, et al. Long-term outcomes in patients with mucinous, medullary, tubular, and invasive ductal carcinomas after lumpectomy. Am J Surg. 2007; 194:527–531.
Article
12. Fisher ER, Anderson S, Redmond C, Fisher B. Pathologic findings from the National Surgical Adjuvant Breast Project protocol B-06: 10-year pathologic and clinical prognostic discriminants. Cancer. 1993; 71:2507–2514.
Article
13. Ellis IO, Galea M, Broughton N, Locker A, Blamey RW, Elston CW. Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up. Histopathology. 1992; 20:479–489.
Article
14. Oh JW, Park S, Kim JH, Koo JS, Hur H, Yang WI, et al. Clinical analysis of medullary carcinoma of the breast. J Breast Cancer. 2009; 12:47–53.
Article
15. Rapin V, Contesso G, Mouriesse H, Bertin F, Lacombe MJ, Piekarski JD, et al. Medullary breast carcinoma. A reevaluation of 95 cases of breast cancer with inflammatory stroma. Cancer. 1988; 61:2503–2510.
Article
16. Edge SB. American Joint Committee on Cancer. American Cancer Society. AJCC Cancer Staging Handbook: from the AJCC Cancer Staging Manual. 7th ed. New York: Springer;2010.
17. Bloom HJ, Richardson WW. Histological grading and prognosis in breast cancer: a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer. 1957; 11:359–377.
Article
18. Anderson WF, Chu KC, Chang S, Sherman ME. Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinoma. Cancer Epidemiol Biomarkers Prev. 2004; 13:1128–1135.
19. Korean Breast Cancer Society. Breast Cancer Facts & Figures. Seoul: Korean Breast Cancer Society;2012.
20. Flucke U, Flucke MT, Hoy L, Breuer E, Goebbels R, Rhiem K, et al. Distinguishing medullary carcinoma of the breast from high-grade hormone receptor-negative invasive ductal carcinoma: an immunohistochemical approach. Histopathology. 2010; 56:852–859.
Article
21. Malyuchik SS, Kiyamova RG. Medullary breast carcinoma. Exp Oncol. 2008; 30:96–101.
22. Kuroda H, Tamaru J, Sakamoto G, Ohnisi K, Itoyama S. Immunophenotype of lymphocytic infiltration in medullary carcinoma of the breast. Virchows Arch. 2005; 446:10–14.
Article
23. Reinfuss M, Stelmach A, Mitus J, Rys J, Duda K. Typical medullary carcinoma of the breast: a clinical and pathological analysis of 52 cases. J Surg Oncol. 1995; 60:89–94.
Article
24. Huober J, Gelber S, Goldhirsch A, Coates AS, Viale G, Öhlschlegel C, et al. Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trials. Ann Oncol. 2012; 23:2843–2851.
Article
25. Fisher ER, Kenny JP, Sass R, Dimitrov NV, Siderits RH, Fisher B. Medullary cancer of the breast revisited. Breast Cancer Res Treat. 1990; 16:215–229.
Article
26. Thurman SA, Schnitt SJ, Connolly JL, Gelman R, Silver B, Harris JR, et al. Outcome after breast-conserving therapy for patients with stage I or II mucinous, medullary, or tubular breast carcinoma. Int J Radiat Oncol Biol Phys. 2004; 59:152–159.
Article
27. Martinez SR, Beal SH, Canter RJ, Chen SL, Khatri VP, Bold RJ. Medullary carcinoma of the breast: a population-based perspective. Med Oncol. 2011; 28:738–744.
Article